Screening of antitubercular compound library identifies novel ATP synthase inhibitors of Mycobacterium tuberculosis

Tuberculosis ◽  
2018 ◽  
Vol 108 ◽  
pp. 56-63 ◽  
Author(s):  
Sunil Kumar ◽  
Rukmankesh Mehra ◽  
Sumit Sharma ◽  
Naveen Prakash Bokolia ◽  
Diksha Raina ◽  
...  
2021 ◽  
Author(s):  
Yuping Ning ◽  
Yi Cai ◽  
Youchao Dai ◽  
Fuxiang Li ◽  
Siwei Mo ◽  
...  

Mitochondria as a highly dynamic organelle continuously changes morphology and position during its life cycle. Mitochondrial dynamics including fission and fusion play a critical role in maintaining functional mitochondria for ATP production, which is directly linked to host defense against Mtb infection. However, how macrophages regulate mitochondrial dynamics during Mycobacterium tuberculosis (Mtb) infection remains elusive. In this study, we found that Mtb infection induced mitochondrial fusion through enhancing the expression of mitofusin 1 ( MFN1 ), which resulted in increased ATP production. Silencing MFN1 inhibited mitochondrial fusion and subsequently reduced ATP production, which, in turn, severely impaired macrophages mycobactericidal activity by inhibiting autophagy. Impairment of mycobactericidal activity and autophagy was replicated using oligomycin, an inhibitor of ATP synthase. In summary, our study revealed MFN1-mediated mitochondrial fusion is essential for macrophages mycobactericidal activity through the regulation of ATP dependent autophagy. MFN1-mediated metabolism pathway might be targets for development of host direct therapy (HDT) strategy against TB.


2005 ◽  
Vol 10 (7) ◽  
pp. 725-729 ◽  
Author(s):  
Upasana Singh ◽  
Vinita Panchanadikar ◽  
Dhiman Sarkar

Mycobacterium tuberculosis glutamine synthetase (GS) is an essential enzyme involved in the pathogenicity of the organism. The screening of a compound library using a robust high-throughput screening (HTS) assay is currently thought to be the most efficient way of getting lead molecules, which are potent inhibitors for this enzyme. The authors have purified the enzyme to a >90% level from the recombinant Escherichia coli strain YMC21E, and it was used for partial characterization as well as standardization experiments. The results indicated that the Kmof the enzyme for L-glutamine and hydroxylamine were 60 mM and 8.3 mM, respectively. The Km for ADP, arsenate, and Mn2+ were 2 [.proportional]M, 5 [.proportional]M, and 25 [.proportional]M, respectively. When the components were adjusted according to their Km values, the activity remained constant for at least 3 h at both 25° C and 37° C. The Z′ factor determined in microplate format indicated robustness of the assay. When the signal/noise ratios were determined for different assay volumes, it was observed that the 200-[.proportional]l volume was found to be optimum. The DMSO tolerance of the enzyme was checked up to 10%, with minimal inhibition. The IC50 value determined for L-methionine S-sulfoximine on the enzyme activity was 3 mM. Approximately 18,000 small molecules could be screened per day using this protocol by a Beckman Coulter HTS setup.


Biochimie ◽  
2019 ◽  
Vol 165 ◽  
pp. 156-160 ◽  
Author(s):  
Aditi Chatterjee ◽  
Sapna Pandey ◽  
Ekta Dhamija ◽  
Swati Jaiswal ◽  
Shivraj M. Yabaji ◽  
...  

2020 ◽  
Vol 64 (8) ◽  
Author(s):  
Matthew B. McNeil ◽  
Heath W. K. Ryburn ◽  
Liam K. Harold ◽  
Justin F. Tirados ◽  
Gregory M. Cook

ABSTRACT Bedaquiline, an inhibitor of the mycobacterial ATP synthase, has revolutionized the treatment of Mycobacterium tuberculosis infection. Although a potent inhibitor, it is characterized by poorly understood delayed time-dependent bactericidal activity. Here, we demonstrate that in contrast to bedaquiline, the transcriptional inhibition of the ATP synthase in M. tuberculosis and Mycobacterium smegmatis has rapid bactericidal activity. These results validate the mycobacterial ATP synthase as a drug target with the potential for rapid bactericidal activity.


2020 ◽  
Author(s):  
Dr. Mustafa Alhaji Isa

<p>ATP synthase subunit c (AtpE) is an enzyme that catalyzes the production of ATP from ADP in the presence of sodium or proton gradient from <i>Mycobacterium tuberculosis</i> (MTB). This enzyme considered an essential target for drug design and its shares the same pathway with the target of Isoniazid. Thus, this enzyme would serve as an alternative target of the Isoniazid. The 3D model structure of the AtpE was constructed based on the principle of the homology modeling using the Modeller9.16. The developed model was subjected to the energy minimization and refinement using molecular dynamic (MD) simulation. The minimized model structure was searched against Zinc and PubChem database to determine ligands that bind to the enzyme with minimum binding energy using RASPD and PyRx tool. A total of 4776 compounds capable of binding to AtpE with minimum binding energies were selected. These compounds further screened for physicochemical properties (Lipinski rule of five). All the compounds that possessed the desirable properties selected and used for molecular docking analysis. Five (5) compounds with minimum binding energies ranged between ─8.69, and ─8.44kcal/mol, less than the free binding energy of ATP were selected. These compound further screened for the absorption, distribution, metabolism, excretion, and toxicity (ADME and toxicity) properties. Of the five compounds, three (ZINC14732869, ZINC14742188, and ZINC12205447) fitted all the ADME and toxicity properties and subjected to MD simulation and Molecular Mechanics Generalized Born and Surface Area (MM-GBSA) analyses. The results indicated that the ligands formed relatively stable complexes and had free binding energies, less than the binding energy of the ATP. Therefore, these ligands considered as prospective inhibitors of MTB after successful experimental validation</p>


2016 ◽  
Vol 100 (12) ◽  
pp. 5415-5426 ◽  
Author(s):  
Vikrant S. Rajput ◽  
Rukmankesh Mehra ◽  
Sanjay Kumar ◽  
Amit Nargotra ◽  
Parvinder Pal Singh ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document